Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Understanding the differences between value and growth investing strategies is crucial for your investment approach. Discover more insights here.
25,836 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Toll Brothers raises its 2026 delivery guidance on persistent luxury demand and better-than-expected absorption. The ...
A May 2026 radio segment turns debt payoff into a personal bet, highlighting how dave ramsey’s behavioral finance tec...
A niche tanker freight ETF has surged roughly 700% this year, outperforming Micron. Here’s what’s driving the move, t...
USD Private unveils a closed digital asset platform featuring a programmed price path from $1 to $1 million over four...
When veterans return with their first original album in years, the headlines focus on the music. What truly stands ou...
Alcoa faced a sharp weekly decline as aluminum prices cooled and geopolitics added volatility. This guide breaks down...
The high-cost DC release posted a weak opening and was trimmed after screenings, fueling questions about DC Studios’ ...
The Antinozzi Group rejoined Compass in Houston after a period with REMAX, led by Joe Antinozzi and Kristin Weaver. I...
California is backing electric vehicle buyers with a new point-of-sale rebate program. For Rivian, this policy shift ...
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
As existing-home prices hit record highs, builders in 10 U.S. metro areas are offering discounts on new homes. The mo...